MEA Mammography Market

MEA Mammography Market Size (2022 to 2027)

The Middle East & Africa mammography market is estimated to be around USD 103.22 million in 2022. It is projected to reach USD 122.48 million by the end of 2027, growing at a compound annual growth rate (CAGR) of 4.2% between 2022 to 2027.

The higher mortality rate related to breast cancer has raised the need to diagnose the patients, resulting in an increasing demand for mammography devices that help in the early diagnosis of cancer. Mammography is a standard diagnostic and screening technique used to screen breast tissues for malignant tissues. The testing is done through low-dose X-rays to get detailed imaging of the inside of the breast. Screening mammography involves random checking among women for breast cancer without any signs of the disease. At the same time, diagnostic mammography is undertaken if there are any symptoms of the disease and can also be used in evaluating the results of the screening mammogram.

The rising cancer population, the evolution of new breast imaging technologies, the rising aging population, and the increasing awareness of cancer symptoms drive the growth of the mammography market in the MEA region.

However, the growth of the mammography market in the MEA is anticipated to be hindered by the huge costs associated, stringent regulatory laws, and side effects associated with mammography.

This research report on the Middle East and Africa mammography market has been segmented and sub-segmented into the following categories:

By Product: 

• 3D mammograms
• Digital
• Analog system
• Film Screens
• Biopsy Systems
• Others

By Technology: 

• Analog
• Digital
• Breast tomosynthesis

By Application: 

• Screening
• Diagnostics

By Country: 

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

The MEA market accounted for a moderate share of the worldwide market in 2021 and is expected to grow at a steady CAGR during the forecast period.

In the Middle East and Africa, the UAE mammography market is growing at the highest CAGR during the forecast period. Rising breast cancer cases are majorly driving market growth in this country. The Ministry of Health and Prevention launched an initiative, ‘scan today not tomorrow,’ which increased the demand for mammography. There are many medical centers in the UAE which are providing the service of mammography for breast cancer. The government has taken the initiative to create awareness regarding breast cancer and early diagnostics, thus boosting market growth. An organization like the Pink Caravan is also doing a campaign for the scanning of breast cancer. 

Following UAE, Israel is predicted to hold a considerable share of the MEA market during the forecast period. The Israel cancer association promotes the early detection of breast cancer, thus increasing the demand for mammography. In Israel, technological advancement in mammography is increasing the demand for mammography. The ISRAEL21c is a new mammography device with the latest technology in clinical trials. 

The South African market is predicted to grow at a healthy CAGR during the forecast period. The Cancer Association of South Africa is taking the initiative to promote breast cancer screening. It is recommended that mammography be screened annually for women aged 40 to 54, boosting the market growth. 

KEY MARKET PLAYERS:

Companies playing a leading role in the Middle East & Africa mammography market profiled in the report include Fujifilm, GE Healthcare, Hologic, Metaltronica, Philips Healthcare, Planmed, Siemens Healthcare, Sonocine, and Toshiba Medical Systems.